publication date: Jul. 22, 2016

Conversation with The Cancer Letter

Weber: We Cannot Completely Ban Guns From MD Anderson’s Campus

 

In response to Texas concealed carry laws, MD Anderson proposed a plan that would allow guns only in designated buildings—the rest, specifically areas of worship and hospital facilities, are gun-exclusion zones.

The UT System Board of Regents approved the cancer center’s recommendations on campus carry July 15.

“We cannot invoke a policy that explicitly or implicitly bans guns from campus, so the primary message was we are going to follow Texas law,” said Max Weber, associate vice president and deputy chief compliance officer at University of Texas MD Anderson Cancer Center. “I think we sort of fell into this law incidentally…

“We are a comprehensive cancer center. We are in the business of healing and curing cancer. We’re not a traditional school or university.”

Weber spoke with Katie McKinney, a reporter with The Cancer Letter.

 

Katie McKinney: What was the MD Anderson administration’s initial response to campus carry?

Max Weber: Their initial response was a clear communication to all involved, that no matter what the final outcome of our plan would be, we would follow the law. We’re mandated because we are an institution of higher education to follow the law.

We have no ability to opt-out; nor, by statute, do we have an ability to completely ban guns from campus. That’s threaded throughout the bill that is now law. We cannot invoke a policy that explicitly or implicitly bans guns from campus, so the primary message was we are going to follow Texas law.

KM: Was the Texas Board of Regents decision well received at MD Anderson?

MW: … Continue reading 42-29 Weber: We Cannot Completely Ban Guns From MD Anderson’s Campus

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.